Picture of Viatris logo

VTRS Viatris Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Annual cashflow statement for Viatris, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
C2022
December 31st
C2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1,2692,07954.7-634-3,515
Depreciation
Deferred Taxes
Non-Cash Items909-1,1591,2031,1304,195
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-1,805-923-711-319-686
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Taxes Payable
Net Change in Other Assets & Liabilities
Cash from Operating Activities3,0172,9992,9002,3032,316
Capital Expenditures-509-443-475-347-465
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items3921,917-3902,14837.4
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-1181,474-8651,801-428
Financing Cash Flow Items-514-19.5-230206-235
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-3,012-3,878-2,302-4,330-1,294
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-144556-269-258612